Helping European biotechs develop their China market entry strategy
Access Biotech China (ABC) is a new conference and partnering event focused on helping European biotech companies to access the Chinese Life Sciences & Health sector.
With a huge patient population, strong governmental support for the biotech sector and Chinese investors with a growing appetite for foreign investments, China is becoming increasingly attractive for biotech companies seeking BD partnerships, new markets and capital to finance growth plans. If your company does not have a China focus yet, then join Access Biotech China and take your first steps to develop your China strategy to enter the Chinese biotech sector.
ABC will provide you with valuable insights in the Chinese Life Sciences & Health sector. It will bring best practises to the stage, inspire you to explore the opportunities and help you to avoid the pitfalls made by others. It will connect you with China experts and the right partners to enter or expand in the Chinese market.
The first edition of ABC is planned as a hybrid event with a face-to-face event at BioPartner Center in Leiden on 14 October and a virtual programme & partnering event on 15 October.